Search research articles
Contact Us
Filters
Showing results (171-180 of 185) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer
R Jakesz, H Hausmaninger, K Haider, et al.
Onkologie
|
May 29, 2003
Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients
F Ploner, R Jakesz, H Hausmaninger, et al.
Breast (Edinburgh, Scotland)
|
May 28, 2019
Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer
C F Singer, M Filipits, S W Jahn, et al.
British Journal of Cancer
|
September 27, 2007
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
W Schippinger, H Samonigg, R Schaberl-Moser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2015
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype
M Gnant, I Sestak, M Filipits, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 9, 2009
ONCOPOOL - a European database for 16,944 cases of breast cancer
R W Blamey, B Hornmark-Stenstam, G Ball, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2012
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer
P Dubsky, M Filipits, R Jakesz, et al.
British Journal of Cancer
|
March 21, 2013
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
G Pfeiler, H Stöger, P Dubsky, et al.
British Journal of Cancer
|
October 26, 2013
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients
P Dubsky, J C Brase, R Jakesz, et al.
Zentralblatt Fur Chirurgie
|
March 4, 1999
[Therapy studies of the Austrian Breast Cancer Group (ABC)]
R Jakesz, H Hausmaninger, H Samonigg, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 185) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Randomized trial of low-dose chemotherapy added to tamoxifen in patients with receptor-positive and lymph node-positive breast cancer
R Jakesz, H Hausmaninger, K Haider, et al.
Onkologie
|
May 29, 2003
Randomised trial: One cycle of anthracycline-containing adjuvant chemotherapy compared with six cycles of CMF treatment in node-positive, hormone receptor-negative breast cancer patients
F Ploner, R Jakesz, H Hausmaninger, et al.
Breast (Edinburgh, Scotland)
|
May 28, 2019
Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer
C F Singer, M Filipits, S W Jahn, et al.
British Journal of Cancer
|
September 27, 2007
A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer
W Schippinger, H Samonigg, R Schaberl-Moser, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 4, 2015
Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype
M Gnant, I Sestak, M Filipits, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 9, 2009
ONCOPOOL - a European database for 16,944 cases of breast cancer
R W Blamey, B Hornmark-Stenstam, G Ball, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 5, 2012
EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer
P Dubsky, M Filipits, R Jakesz, et al.
British Journal of Cancer
|
March 21, 2013
Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial
G Pfeiler, H Stöger, P Dubsky, et al.
British Journal of Cancer
|
October 26, 2013
The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients
P Dubsky, J C Brase, R Jakesz, et al.
Zentralblatt Fur Chirurgie
|
March 4, 1999
[Therapy studies of the Austrian Breast Cancer Group (ABC)]
R Jakesz, H Hausmaninger, H Samonigg, et al.
Page
of 19